Jazz Pharmaceuticals posts $215 million in net income for third quarter

Green Market Report
By John SchroyerNov 7, 2024, 1:26 pm127 ptsTop
Ireland-based Jazz Pharmaceuticals (Nasdaq: JAZZ), the makers of Epidiolex, reported net income in the third quarter this year of $215 million, with revenue up 9% year-over-year. That brings the company’s total net income for the year so far to $369 million on revenue of $2.9 billion. The company’s…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Texas AG Suing City of Dallas Over Voter-Backed Cannabis Decriminalization Policy 69

The Discreet Stoner’s Guide to Thanksgiving 68

New Hampshire governor-elect reiterates opposition to adult-use cannabis 67

Texas AG challenges marijuana decriminalization in Dallas 66

Cannabis REIT Nova to liquidate, sell assets for $3.7M 64

Illinois group buys three Chicago dispensaries from Okay Cannabis 63

Illinois hemp vape maker sued for having too much THC 63

Here’s how marijuana retailers can boost their e-commerce sales 60

About NewsBudz

NewsBudz is a marijuana and medical cannabis news app. The site delivers a daily feed of the latest cannabis news. We aggregate over 30 of the web's best sources for news about marijuana, hemp and legalization to keep you informed.

Stay on top of the latest news headlines, trends and developments worldwide around recreational and medical marijuana. Sit back and relax, while you read learn and share. On the web or your mobile device, NewsBudz is your cannabis news stream.